Wound Care Redefined

Advanced Wound Care Distribution For Clinical Excellence

Request Onboarding Pack
GDP Compliant
MHRA-Ready Documentation
Batch Traceability
Next Day Fulfilment

What is Trivient?

Trivient is a medical device distributor specialized in advanced wound care solutions.

Regulatory & Quality Assurance

Maintaining quality, traceability, and regulatory confidence from supply to patients
  • Regulatory Gateway to the UK: Fully integrated support for international medical technologies entering the UK market under UK MDR 2002 (as amended), including MHRA registration and transition to UKCA compliance.
  • Assured Quality & Traceability: Operations aligned to ISO 13485, with rigorous batch tracking and documentation to meet the demands of sterile wound care distribution.
  • GDP-Led Distribution Integrity: Strict adherence to Good Distribution Practice, including controlled environments, to protect product

Clinical & Commercial Access

Supporting adoption clinically effective technologies acute and community care
  • Clinically Focused Market Entry: Selective introduction of technologies that improve clinical efficiency and patient outcomes across acute, community, and long-term care settings.
  • Operational Burden Reduction Portfolio: A strategy designed to simplify workflows for healthcare professionals while supporting faster patient recovery.
  • System-Wide Value Creation: Commitment to making high-quality wound care more accessible and cost-effective across the UK healthcare system.

What is Trivient?

Trivient is a medical device distributor specialized in advanced wound care solutions.

Regulatory & Quality Assurance

Maintaining quality, traceability, and regulatory confidence from supply to patients
Regulatory Gateway to the UK

Fully integrated support for international medical technologies entering the UK market under UK MDR 2002 (as amended), including MHRA registration and transition to UKCA compliance.

Assured Quality & Traceability

Operations aligned to ISO 13485, with rigorous batch tracking and documentation to meet the demands of sterile wound care distribution.

GDP-Led Distribution Integrity

Strict adherence to Good Distribution Practice, including controlled environments, to protect product

Clinical & Commercial Access

Supporting adoption clinically effective technologies acute and community care
Clinically Focused Market Entry

Selective introduction of technologies that improve clinical efficiency and patient outcomes across acute, community, and long-term care settings.

Operational Burden Reduction Portfolio

A strategy designed to simplify workflows for healthcare professionals while supporting faster patient recovery.

System-Wide Value Creation

Commitment to making high-quality wound care more accessible and cost-effective across the UK healthcare system.

Optimising Wound Care

Trivient is a UK supplier of advanced wound care products, supporting nursing homes, community providers, and clinical settings. We supply dressings and wound care solutions designed for the management of complex, chronic, and high risk wounds.

Our focus is on improving patient outcomes through appropriate product selection, consistent availability, and reliable supply. By ensuring access to effective advanced therapies, we help care teams deliver better wound outcomes efficiently while organisations maintain control over cost and resources.

Our Approach

Maximising Value Across Acute & Community Healthcare

Evidence-Based Outcomes
  • Prioritisation of technologies supported by robust clinical evidence
  • Demonstrated improvements in healing rates for chronic and complex wounds
  • Focus on solutions suitable for high-risk patient populations
Operational Simplicity
  • Protocol-driven solutions designed to reduce intervention frequency
  • Simplified care pathways to support overstretched clinical teams
  • Emphasis on patient safety alongside workflow efficiency
Evidence-Based Outcomes
  • Prioritisation of technologies supported by robust clinical evidence
  • Demonstrated improvements in healing rates for chronic and complex wounds
  • Focus on solutions suitable for high-risk patient populations
Operational Simplicity
  • Protocol-driven solutions designed to reduce intervention frequency
  • Simplified care pathways to support overstretched clinical teams
  • Emphasis on patient safety alongside workflow efficiency
Focused on Patient Outcomes

Clinically Appropriate Products
We focus on advanced wound care products that are appropriate for routine use in real care settings, with clear indications and consistent performance.
Practical Impact
Our product range supports effective management of chronic and complex wounds, emphasizing ease of use, reliability, and consistent outcomes.
Suitable for Complex Care
Products are chosen for use in patients with higher care needs, where consistency and predictability are critical to maintaining standards of care.

Operational Simplicity

Lower Intervention Frequency
We focus on solutions that reduce intervention frequency and simplify the care pathway whilst prioritising patient safety.
Support for Overstretched Teams
By reducing hands on time per patient, our products may help ease workload pressures on clinical teams.
Easy Integration into Existing Practice
Our products are designed to integrate into existing wound care routines without requiring changes to established processes.

Reliable Access to Advanced Wound Care

Supporting adoption of clinically effective technologies in acute and community care

Selective Product Introduction: We provide a focused portfolio of wound care technologies selected for clinical relevance and suitability for UK care settings.
Route to Market: Products are positioned for adoption across acute, community, and long-term care environments through established distribution infrastructure.
Commercial Viability: Products are selected for commercial feasibility within UK healthcare settings with relevance to patient care and cost efficiency.

Regulatory & Quality Assurance

Maintaining quality, traceability, and regulatory confidence

UK Market Entry
We support the introduction of international medical technologies into the UK market in-line with UK MDR 2002 (as amended), including MHRA registration and UKCA requirements.
Quality Systems
Our operations are aligned with ISO 13485 principles, with documented processes supporting quality management and control.
GDP Compliant Distribution
Storage and distribution are managed in accordance with Good Distribution Practice, with traceability and controlled environments to protect product integrity throughout handling and delivery.